School of Medicine
Showing 2,151-2,200 of 2,203 Results
-
Celina Yong, MD, MBA, MSc
Associate Professor of Medicine (Cardiovascular Medicine)
BioCelina Yong, MD, MBA, MSc is Director of Interventional Cardiology at the Palo Alto VA Medical Center and an Associate Professor in the Division of Cardiovascular Medicine at Stanford. Dr. Yong completed her medical training at Stanford School of Medicine and her internal medicine residency at the University of California, San Francisco. She completed her cardiology and interventional cardiology fellowships at Stanford, including serving as Chief Fellow. As a Marshall Scholar, she completed a Masters in Health Policy, Planning and Financing from the London School of Economics and an MBA from Oxford.
Dr. Yong’s current research focuses on understanding and reducing inequities in cardiovascular care for patients, as well as resolving gender imbalances in the medical profession itself. She is actively involved in clinical trials of novel devices for percutaneous coronary and structural intervention, and performs structural and coronary interventions at the Palo Alto VA Hospital. -
Shady Younis
Instructor, Medicine - Immunology & Rheumatology
BioShady Younis, PhD is an instructor at the division of Immunology and Rheumatology at Stanford University. He received his PhD in Medical Sciences from Uppsala University in Sweden. He later joined Dr. William Robinson’s Lab at Stanford University as Wallenberg postdoctoral fellow, where he characterized the pathogenic role of cytotoxic CD8+ T cells in rheumatoid arthritis. His current research aimed at elucidating the underlying triggers of pathogenic B cell responses in a spectrum of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). He uses computational methodologies alongside cutting-edge high-throughput sequencing technologies to characterize the autoreactive B and T cells. The overarching research objective of his research is to unravel the mechanistic roles of Epstein-Barr Virus (EBV) reactivation in activating and transforming autoreactive B cells in the development of autoimmunity.
-
Grace Chen Yu
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Yu is a modern-day version of the “old-fashioned family doc” who delights in caring for patients from “cradle to grave,” while also promoting the health of her community and developing the future leaders of family medicine. On any particular day, one might find her counseling a long-time smoker on quitting, draining an abscess in clinic, delivering a baby, doing a phone (or sometimes home) visit with one of her elderly patients, lecturing about High-Value Health Care, facilitating a diabetes group visit, singing the praises of coordinated primary care to politicians, discussing end-of-life options with a hospitalized patient, or sharing some of her stories as mother-doctor-teacher with one of her advisees. In 2016, adding one more hat to the mix, Dr. Yu became Program Director of the 24-resident Stanford Health Care - O’Connor Hospital Family Medicine Residency Program. Whereas the old-fashioned family doc was a master at caring for patients at different ages and stages of life, as a modern-day family physician, Dr. Yu is committed to researching ways to do so more effectively and efficiently. She considers it a privilege to be a part of her patients' lives and hopes to help both her patients and her trainees find a path to better health and happiness. To keep herself in great health, Dr. Yu enjoys playing the piano, photography, scuba diving, adventure travel (all the more adventurous with her three children in tow!), and spending time with her family and friends.
-
Ilana Rachel Yurkiewicz
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Yurkiewicz is a primary care doctor with fellowship training and board certification in internal medicine, oncology, and hematology. She is a clinical assistant professor of primary care and population health in the Department of Medicine at Stanford University School of Medicine.
She provides expert, compassionate clinical care for patients, advocates for them as a medical journalist, and researches ways to improve their lives through better health and quality of life.
She has a special interest in cancer survivorship and improving transitions between oncology and primary care. Her practice is uniquely focused on providing comprehensive care for patients with a history of cancer as well as those carrying genetic diagnoses of elevated risk.
For each patient, her goal is to provide thoughtful, compassionate, and holistic care.
As a journalist, she strives to bridge the gaps between academic medicine and everyday lives. She has been a regular columnist for Scientific American and MDEdge. Her writing has appeared in numerous publications and been reprinted in The Atlantic and The Best American Science and Nature Writing anthology.
Dr. Yurkiewicz is the author of the book Fragmented: A Doctor’s Quest to Piece Together American Health Care from the publisher W.W. Norton.
She has co-authored research articles that appeared in the New England Journal of Medicine, American Journal of Clinical Oncology, Genetics in Medicine, and other peer-reviewed publications. She also has served as an editorial board member of the journal Hematology News.
An additional interest of Dr. Yurkiewicz is bioethics. She interned with the Presidential Commission for the Study of Bioethical Issues, conducted extensive research, and published her discoveries in the New England Journal of Medicine, Penn Bioethics Journal, and Ivy Journal of Ethics.
She has presented her research discoveries to her peers at meetings of the American Society of Hematology, Society of Hospital Medicine, National Society of Genetic Counselors, and elsewhere.
She is a member of the American College of Physicians and an associate member of the American Society of Clinical Oncology and American Society of Hematology. -
Roham Zamanian
Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly Interests1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.
2. Prevalence and Treatment of Insulin Resistance in PAH.
3. Role of inflammation and proteomic signature in PAH
4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.
5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension
6. Assessment of microvascular function in PAH. -
Astrid Nicole Zamora
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
BioDr. Astrid N. Zamora is a public health researcher and epidemiologist. Her work has utilized robust birth cohort data to examine associations between diet and environmental pollutants with sleep and metabolic health outcomes among adolescents and midlife women.
Following her Master of Public Health degree at UC Berkeley School of Public Health, Dr. Zamora completed her PhD at the University of Michigan School of Public Health. As a doctoral trainee at Michigan, her dissertation research, funded by a Research Supplement to Promote Diversity in Health-Related Research from NIH/NIEHS, focused on examining the interplay between exposure to endocrine-disrupting chemicals, sleep, and metabolic health risk among pubertal adolescents and peri-menopausal women from Mexico City.
As a current NHLBI T32 postdoctoral research fellow at Stanford University School of Medicine, Dr. Zamora is receiving training in RCT study design and citizen science methods, learning how to bridge her training in epidemiology with community-based research approaches, thereby ensuring that her research agenda maintains a meaningful connection to the community and its real-world context. The goal of her current research, bolstered by her previous and ongoing training, is to explore the interconnections between diet, the built environment, and physical activity. She is particularly focused on understanding how these factors relate to psychosocial and cardiometabolic health amongst Latinx communities across the life course. -
James L. Zehnder, M.D.
Professor of Pathology (Research) and of Medicine (Hematology)
Current Research and Scholarly InterestsMy main research and clinical interests include molecular pathogenesis of acquired cytopenias, genetic testing for inherited non-malignant hematologic disorders, next-generation sequencing approaches to T and B cell clonality testing, somatic mutations in cancer and assessment of minimal residual disease in cancer patients.
-
Huaiyu Zhang
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Zhang obtained her MS in Neuroscience from the University of Southern California and earned her PhD in Clinical Psychology from Emory University. She completed both her predoctoral internship and postdoctoral fellowship at Emory University School of Medicine. Prior to joining Stanford in 2023, Dr. Zhang supported survivors of interpersonal violence at the University of California San Francisco Trauma Recovery Center for over seven years. Dr. Zhang embraces an integrative, contextualized, evidence-informed, and strength-based approach to teaching, supervision, and clinical care. She provides services in English and Mandarin.
-
Tian Yi Zhang, MD, PhD
Assistant Professor of Medicine (Hematology)
BioDr. Zhang is a board-certified hematologist. She is also an assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology.
In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. For each patient, she develops a personalized care plan encompassing novel treatment options.
Her research activities include conducting early phase clinical trials, investigator initiated clinical trials (IITs), studying the immune repertoire in patients with myeloid malignancies, and exploring cholesterol metabolic dependencies of acute myeloid leukemia (AML).
She was the recipient of an A.P. Giannini Foundation fellowship award, which supports innovative research. The award helped fund Dr. Zhang’s study of how AML cells interact with other cells in bone marrow. A significant finding confirmed that AML cells secrete a protein that suppresses the production of red blood cells, the same protein that causes inflammation in disorders such as rheumatoid arthritis and Crohn’s disease.
Her many other honors include the National Cancer Institute Career Development (K08) Award, the American Society of Hematology (ASH) Research Training Award for Fellows, Stanford Cancer Institute - American Cancer Society (SCI-ACS) Pilot Grant and Best ASH Abstract Award two years in a row. She also has earned recognition from the National Institutes of Health and American College of Physicians.
She has published her research findings on topics such as advanced therapy for high-risk myelodysplastic syndromes and reversal of bone marrow failure induced by AML. Her work has appeared in Leukemia & Lymphoma, Science Translational Medicine, Cancer Research, the Journal of Clinical Investigation, Journal of Immunology, and elsewhere.
Dr. Zhang is a member of the American Association of Cancer Research and American Society of Hematology. She advises and mentors Stanford medical students, residents and fellows. She delivers invited lectures to faculty and fellows. In addition, she has been an invited speaker on the topic of acute myeloid leukemia at the Association of Northern California Oncologists Update on Hematological Malignancies. -
Han Zhu
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Zhu is an Assistant Professor of Medicine whose clinical and research expertise focuses on cardio-oncology and cardio-immunology. She specializes in the cardiovascular care of patients undergoing therapies for cancer, with a particular focus on the effects of immunotherapies on the heart. She received a bioengineering degree from MIT, medical degree from Case Western Reserve University, and completed clinical cardiology fellowship and internal medicine residency training at Stanford University School of Medicine. Dr. Zhu’s laboratory focuses on myocarditis, cardiac inflammation, and the effects of cancer therapeutics on the cardiovascular system. Her current research employs clinical data, bio-banked samples, and in vivo/in vitro preclinical models in combination with single-cell technologies to study immune-based toxicities in the heart. Dr. Zhu's clinic sees cardio-oncology and cardio-immunology patients and her lab focuses on devising new methods for minimizing cardiovascular complications in the cancer and autoimmune patient populations.
-
Daniel Zimmer
Postdoctoral Scholar, Infectious Diseases
Current Research and Scholarly InterestsMy research focuses on the scientific history of anthropogenic existential risk and its impact on Western political thought. I focus in particular on the development of massed thermonuclear arsenals during the 1950s, the rise of Earth System science and attendant ecological risks during the 1980s, and the anxieties surrounding the prospect of artificial super intelligence that took hold in the 2000s.
-
Susan Ziolkowski, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Ziolkowski is a board-certified nephrologist with a passion for caring for persons with chronic kidney disease. She is a clinical assistant professor in the Stanford Department of Medicine’s Division of Nephrology and has a special focus on treating patients with cancer and kidney disease. She is active both in research and teaching endeavors to further advance this field.
She provides patient care at the Stanford Health Care kidney clinics in Palo Alto and Emeryville. For each patient, she prepares a care plan that is comprehensive, compassionate, and personalized to individual needs. Her goal is to help every patient achieve the best possible health and quality of life.
Dr. Ziolkowski has co-authored articles on her research findings in the American Journal of Kidney Disease, Journal of Renal Nutrition, Peritoneal Dialysis International, and other journals. She has made presentations to her peers at meetings of the American Society of Nephrology, National Association for Research in Science Teaching, and other professional organizations.
She enjoys running, yoga, skiing and getting outdoors. -
Andrew Zolopa
Professor of Medicine (Infectious Diseases) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsDr. Zolopas research applies a variety of clinical epidemiologic methods in an effort to optimize antiretroviral therapy and understand the impact of drug resistance on response to ARV. Areas of focus include the clinical application of resistance testing in optimizing antiretroviral therapy, clinical cohorts, trials of antiretroviral therapies and population-based epidemiologic evaluation of HIV resistance and efficacy of ARV therapy. More recently studies focused on premature aging in HIV.
